MAPT and tauopathy: Although our in vitro results suggest that the increase in tauopathy in the LRRK2/TauP301L mice is likely derived from the kinase function of LRRK2, it is possible that in vivo LRRK2 also promotes the aggregation of tau into the insoluble fraction by indirect cellular mechanisms.